NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is administered, with the data uploaded to an app ...

Other common side effects may include injection site reactions ... data published in JAMA Network Open shows that insulin pens could be produced for as little as $0.94 per unit and remain ...

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...

Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type 2 diabetes. Soliqua 100/33 comes as a prefilled single-use pen for injecting the drug under your skin.

NovoLog is also available in pen injector formats. Before Merilog, the FDA has given the go-ahead to two biosimilars of Sanofi's basal insulin product Lantus (insulin glargine) – Viatris ...

Quality scores dipped during the COVID-19 pandemic, but are now at or above 2019 levels in areas such as diabetes and asthma management.

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Smart insulin pens eliminate the guesswork involved in insulin dosing, providing greater convenience for users. Features such as dose memory, missed-dose alerts, and injection time tracking offer ...